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RELATO DE CASO 
SÍNDROME DE HIPOVENTILAÇÃO CENTRAL CONGÊNITA 
ASSOCIADO A DOENÇA DE HIRSCHSPRUNG: UM RELATO DE 
CASO NO TOCANTINS 
CONGENITAL CENTRAL HYPOVENTILATION SYNDROME 
ASSOCIATED WITH HIRSCHSPRUNG’S DISEASE: A CASE REPORT IN 
TOCANTINS 
Nadine Nair de Pina Tavares1, Daniel Jhonatas Silvério de Lima1, Lucas dos 
Santos Alcantara1, Lúcia Caetano Pereira2, Andrea Silva do Amaral3. 
RESUMO 
A síndrome de hipoventilação central congênita (SHCC) é uma desordem genética 
rara, associada a mutações no gene paired-like homeobox 2B (PHOX2B), 
caracterizada por disautonomia e apneia central. A doença de Hirschsprung (DH) 
está presente em cerca de 20% dos casos de SHCC. Este estudo objetiva relatar o 
caso de um neonato que apresentou apneia central recorrente, eliminação tardia 
de mecônio e distensão abdominal diagnosticado com DH associada a SHCC, 
comparando-se os aspectos clínicos esperados e os encontrados pela equipe que 
assistiu a criança. Nota-se um retardo no diagnóstico principalmente pela raridade 
da síndrome e ao seu desconhecimento por parte dos profissionais da saúde. 
Sendo assim, conclui-se ser imprescindível medidas de suporte, diagnóstico e 
tratamento precoces pelo risco de complicações graves que ambas as doenças 
podem acarretar ao recém nascido.    
Palavras-chave: Síndrome de hipoventilação central congênita, síndrome de 
Ondine, gene PHOX2B, doença de Hirschsprung,  síndrome de Haddad. 
 
ABSTRACT 
Congenital central hypoventilation syndrome (CCHS) is a rare genetic disorder 
associated with mutations in paired-like homeobox 2B gene (PHOX2B), 
characterized by dysautonomia and central sleep apnea. Hirschsprung's disease 
(HD) is present in about 20% of CCHS cases. This study aims to report the case of a 
neonate who presented with sleep apnea, late elimination of meconium and 
abdominal distension diagnosed with CCHS associated with HD, comparing the 
clinical aspects expected and those found by the medical team that attended the 
child. There was a delay in the diagnosis, mainly due to the rarity of the syndrome 
and the lack of knowledge about the disease by health professionals. Therefore, it 
is concluded that life support, early diagnosis, and treatment are essential due to 
the risk of serious complications that both diseases can cause to the newborn. 
Keywords: Congenital central hypoventilation syndrome, Ondine’s curse, PHOX2B 
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Congenital central hypoventilation syndrome (CCHS) 
is a rare genetic disorder associated with mutations in paired-
like homeobox 2B gene (PHOX2B), characterized by autonomic 
nervous system (ANS) dysfunction. It causes central sleep 
apnea mainly during non-rapid eye movement sleep, in which 
breath autonomic control predominates.1-4 Patients do not 
show normal physiological responses to hypoxia or 
hypercapnia, leading to alveolar hypoventilation. The 
voluntary breathing control remains intact.2,5,6 The diagnosis is 
made by discarding other pathologies such as central 
neurological lesions or neuromuscular injuries,  neurological 
malformations, cardiopathies and pneumopathies.7 
Robert Mellins et al. published the first description of 
CCHS in 1970.8 It was named after "Ondine", a theatrical play 
Jean Giraudoux wrote in 1938. The plot says Ondine was a 
water nymph from Norse mythology who married Hans. After 
he betrayed her, he is condemned to live awake so that he 
could breathe.1,5 
Until 2009, more than 1,000 cases of the disease with 
the PHOX2B mutation were diagnosed and documented. In 
Japan, the estimated incidence is 1 per 148,000 live births and 
1 per 200,000 live births in France.2,6,8,9 In Brazil, there are 
publications reporting isolated cases, but there is no defined 
epidemiology.1 
In 2003, mutations in PHOX2B were identified as 
responsible for the syndrome.10 This gene is located on 
chromosome 4p13 and its expression pattern involves the 
development of central autonomic circuits as well as of 
peripheral neural crest derivatives.1,2,10-14 Heterozygous 
mutations are known to occur in more than 90% of CCHS 
cases.15 The normal genotype shows a sequence of 20 
polyalanines, designated as "20/20 genotype", there being an 
equivalence relation between the number of alanines added 
through the mutation and the severity of the syndrome 
phenotype.1,8 In patients with CCHS, polyalanine repeat 
expansion mutations (PARM) may manifest genotypes 20/24 
to 20/33 (with 24 to 33 alanines).2,16 The presence of these 
mutations is evidenced by using genetic tests with polymerase 
chain reaction (PCR).1,17 Other types of mutations may occur; 
they are known as non-polyalanine repeat expansion 
mutations (NPARM) of missense, frameshift or nonsense 
types.2,10 They are diagnosed through genetic sequencing.1 
Apnea, cyanosis, and hypercapnia are some of the 
manifestations of CCHS shown in the immediate postpartum.2 
In newborns with CCHS, hypoventilation can be imperceptible 
until they present with recurrent apnea episodes because they 
fail the normal physiological reaction to hypoxia or 
hypercapnia. Hypoglycemia and hyperinsulinemia are also 
reported frequently.1,2,12,13 
Since 1992, studies have shown there is a late onset 
of the syndrome and diffuse impairment of ANS, which 
increases the range of clinical manifestations, such as 
arrhythmias, changes in heart rate, gastroesophageal reflux, 
baroreflex dysfunction, decreased intestinal motility and 
chronic constipation, diaphoresis, orthostatic hypotension, 
pupillary reflex abnormalities and excessive drowsiness.1,5 
Some patients with late onset of the disease may manifest 
symptoms only when submitted to anesthetics or other drugs 
that depress the central nervous system, or after respiratory 
tract infections.2,6,16 
Shorter PARMs (20/24 or 20/25) may present late-
onset CCHS and rarely rely on continuous ventilatory support, 
unlike patients with longer repetitions (20/27 to 20/33) or 
NPARM.2 
Genetic studies found out mutations in PHOX2B gene 
also occur in individuals with complex neural-crest 
involvement including CCHS and Hirschsprung disease (HD) as 
well as early-onset neuroblastoma and other neural crest 
tumors.10 It is known that approximately 15-20% of CCHS 
cases are associated with HD; this association configures the 
Haddad syndrome.1 
HD or congenital megacolon incidence estimate is 1 
per 5,000 live births. It is usually diagnosed during the 
neonatal period after delayed elimination of meconium (> 48 
hours), abdominal distension, and food intolerance. It is 
characterized by aganglionosis in a variable long or short 
segment of the large intestine. Short segment aganglionosis 
happens more frequently, especially in the rectum and 
sigmoid. Due to the involvement of the enteric nervous 
system, symptoms such as intestinal obstruction arise with a 
variation on the degree of constipation. The barium enema is 
the most commonly noninvasive method used to exclude 
other causes of bowel obstruction in neonates prior to rectal 
biopsy.2,18,19 
Tumors derived from neural crest typically manifest 
in the second year of life. Among all CCHS patients, 5-6% have 
these tumors, but the incidence may reach 50% in NPARM 
patients. They are tumors composed of immature neural cells, 
such as the neuroblastoma, ganglioneuroma, and 
ganglioneuroblastoma.1,15 
This study aims to report the case of a newborn 
diagnosed with HD associated with CCHS in Tocantins, 
comparing the clinical aspects expected and those found by 
the medical team that attended the child. 
CASE REPORT 
 Male neonate born by cesarean section without 
complications. Full-term pregnancy (gestational age 38 weeks 
and 5 days), weighing 2,765 g, a stature of 48 cm, a cephalic 
perimeter of 34.5 cm, a thoracic perimeter of 33 cm, Apgar 
score in the first minute of 4 and in the fifth minute of 8. Son 
of non-consanguineous couple . The mother was 26 years old, 
second gestation, a prior cesarean section, no abortion. She 
attended to a full prenatal care, had normal serologies, and "O 
positive" blood type. The membranes were ruptured during 
the c-section with clear oligohydramnios. The investigation of 
infectious foci in the mother was negative. She was hydrated 
and denied vaginal losses. 
 The newborn wept after birth but within the first 
hour presented irregular breathing and bradycardia, requiring 
supplemental oxygen and positive pressure ventilation (PPV) 
with a mask. The patient evolved with a saturation drop, was 
submitted to orotracheal intubation and referred to the 
neonatal intensive care unit (ICU) with a suspected 
cardiopathy. He was admitted to the ICU with PPV, a heart 
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rate of 120 bpm, a temperature of 36.4ºC, an oxygen 
saturation of 92% and glycemia of 54 mg/dl. In the ICU, 
antibiotic therapy was started due to presumptive early 
neonatal sepsis and the newborn was maintained in invasive 
mechanical ventilation (IMV) with low parameters. 
 At the neonatal ICU, extubation was attempted 
numerous times, but it was unsuccessful due to recurrent 
episodes of apnea without a definite cause. 
Within 48 hours a transthoracic Doppler 
echocardiogram revealed a patent foramen ovale of 1.6 mm 
with no hemodynamic repercussions. A transfontanelle 
ultrasonography showed hyperechogenicity in the left 
periventricular white matter with normal Doppler. 
The patient eliminated meconium only on his third 
day of life after rectal stimulation. He evolved with progressive 
abdominal distension; parenteral nutrition was initiated and 
maintained for 5 days. Other causes of intestinal obstruction 
were excluded through imaging and rectal examination; then, 
HD was suggested as a hypothesis by the pediatric surgery 
team, who requested an barium enema performed on his 20th 
day of life. It revealed normal colon size with small retention 
of contrast. Then it was performed a rectal biopsy through 
sphincterotomy, on the 28th day. No ganglion cells were 
observed in the submucosal and myenteric plexuses of the 
biopsied segment, confirming the diagnosis of congenital 
megacolon. Once HD was diagnosed, a loop colostomy was 
scheduled after resolution of the infectious condition. 
Antibiotic therapy was maintained due to the 
presence of Staphylococcus haemolyticus in blood culture. 
Clinical improvement was shown; however, five days after the 
end of the antimicrobial regimen, the patient presented 
clinical worsening. In a new blood culture, the growth of 
Klebsiella pneumoniae was evidenced and an uroculture had 
the presence of fungi; thus, amphotericin B and ampicillin with 
sulbactam were started. After the antibiogram detected 
sensitivity to meropenem, it was initiated. Later 
ultrasonography of the urinary tract presented bilateral small 
renal hydronephrosis; there was no microbial growth in a new 
uroculture. 
Suspicion was raised for CCHS and innate metabolism 
error. An expanded neonatal screening test was performed, 
which did not prove any alterations, neither did the study of 
organic acids in the urine show any abnormalities, discarding 
the last hypothesis. The karyotype of peripheral blood did not 
reveal abnormalities. Subsequently, a molecular biology test 
was performed with PCR followed by fragments analysis. It 
showed the presence of polyalanine allele expansion in the 
PHOX2B gene with 26 repetitions at the 4p13 locus, 
confirming the diagnosis of CCHS. 
On day 46, the patient was transferred to the 
pediatric ICU where tracheostomy and colostomy were 
performed. The sigmoid colon biopsy revealed dilation of the 
intestinal lumen with narrowing in the adjacent segment, 
thinning of the wall and reactive epithelial changes in addition 
to an apparent reduction in the number of ganglion cells in the 
myenteric plexus. 
The patient presented convulsive tonic-clonic 
seizures throughout hospitalization. A electroencephalogram 
showed epileptogenic activity in the right frontocentral region. 
Phenytoin was indicated for seizures prophylaxis. 
Since then, the child has been maintained in VMI 
during sleep and using oxygen mask during the waking period, 
feeding on breast milk and milk formula by gavage, using 
domperidone and omeprazole for gastroesophageal reflux. 
 
DISCUSSION 
 The Brazilian Ministry of Health (MH) never 
registered the number of CCHS cases in Brazil. Based on the 
estimated incidence of CCHS on newborns in France2 and the 
number of live births MH reported through the Live Birth 
Information System (in Portuguese: Sistema de Informações 
sobre Nascidos Vivos), about 14 Brazilians with the disease 
were born in 2016. 
CCHS is a rare entity, however it is notably 
underdiagnosed. To justify this fact, two aspects call attention: 
the variety of phenotypes already described in the literature14 
and the lack of knowledge about the pathology by health 
professionals. Phenotypes vary according to mutations, and 
range from newborns requiring continuous assisted 
ventilation to elderly patients with mild sleep apnea.1 Its rarity 
and relatively recent discovery, the numerous differential 
diagnoses, the difficulty of access to the necessary tests, and 
many other factors, hamper the dissemination of 
acknowledgement about Ondine’s curse among health 
professionals. 
The patient's diagnosis was delayed due to these 
difficulties. Initially, early neonatal sepsis and cardiopathy 
were assumed, two important differential diagnoses that 
should be considered in this case.1 Although, even before the 
diagnosis of CCHS, therapeutic management was started to 
guarantee adequate ventilation and oxygenation to the 
patient. 
These patients require full-time care with oxygen 
saturation monitoring and ventilation, mainly during sleep. A 
multi-professional team trained and experienced in the 
management of the disease and its complications must assist 
them (pediatricians, pediatric surgeons, nurses, 
physiotherapists, nutritionists, speech therapists).1,2,8,9,14 
Some pediatric patients will depend on continuous 
ventilatory support, while others will need support only during 
sleep.8,14 The detailed patient previously, needed ventilatory 
support during sleep and in some instances during the waking 
period, such as after physical exertion, probably because of 
the shorter PARM (genotype 20/26). 
It was decided to perform PPV by tracheostomy 
because it ensures better oxygenation and ventilation 
efficiency in the sleep-wake cycle in neonates and infants. 
Other ventilation options include noninvasive positive 
pressure ventilation (NIPPV) or diaphragm stimulation. NIPPV 
is recommended for older children with less severe 
phenotypes, as it is performed via a nasal catheter, nasal mask 
or face mask. The stimulation of the diaphragm is mainly 
performed in patients who require continuous ventilatory 
support, allowing greater mobility and better life quality.2,14 
As the symptoms of HD emerged, obstructive causes 
were excluded through imaging and rectal examination. The 
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rectal biopsy through sphincterotomy identified aganglionosis 
of parasympathetic plexuses of the rectal segment. 
Subsequent sigmoid colon biopsy identified only 
hypoganglionosis, confirming the extension as a short 
segment disease.20 
It is known that the absence of cells in the 
parasympathetic submucous and myenteric plexus causes the 
HD clinical features, such as the lack of motility in the 
intestinal tract it affects. This shortage of plexuses can lead to 
important complications like functional obstruction, 
enterocolitis or even intestinal perforation. To avoid the 
mentioned complications, it should be diagnosed and treated 
as early as possible. The cure for HD is the excision of the 
aganglionic intestinal segments with reconstruction of the 
intestinal transit.20 The surgeons who attended the detailed 
patient, opted to perform the surgery in two times: firstly a 
loop colostomy, and secondly the reconstruction of the 
intestinal traffic. 
The rectal biopsy is the gold standard for HD 
confirmation or exclusion. One of the tests that may be done 
is the barium enema, despite its sensitivity being low, due to 
recurrent failure to identify transition zone in newborns. Our 
patient had an inconclusive test as the transition zone was not 
visualized, although small retention of intestinal contents was 
identified. Children who have a very short aganglionic 
segment sometimes do not show an obvious transitional zone 
on radiography.20 
In the literature, some isolated cases are described in 
which the patient presented at least one convulsive crisis due 
to acute episodes of hypoxia. Marcus et al. reported children 
who had persistent seizures and required prophylactic 
treatment; they had severe CCHS and received ventilatory 
support in wakefulness. Hopkins et al. addresses seizures in 
CCHS patients to episodes of sustained hypoglycemia and 
hyperinsulinemia.17,12,21 
After positive uroculture for fungi, it was necessary to 
investigate malformations of the genitourinary tract. The 
ultrasonography showed only mild bilateral hydronephrosis 
was identified; no malformations were seen. The patient 
evolved with good diuresis, without related signs or 
symptoms, nor renal scales after the third day of life that 
justified the need for further investigation.22 
 
CONCLUSION 
 CCHS should be suspected when a newborn presents 
with sleep apnea with no apparent cause. HD should be 
considered as a diagnosis in pediatric patients with abdominal 
distension associated with the late elimination of meconium 
during the neonatal period, and after exclusion of other 
causes of bowel obstruction. As soon as differential diagnoses 
have been suspected and discarded, confirmatory tests should 
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